Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3483063013 | Product containing zaleplon (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3717024016 | Zaleplon-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zaleplon-containing product | Is a | Hypnotic agent | false | Inferred relationship | Some | ||
| Zaleplon-containing product | Is a | Sedative agent | false | Inferred relationship | Some | ||
| Zaleplon-containing product | Is a | Hypnotic agent | false | Inferred relationship | Some | ||
| Zaleplon-containing product | Has active ingredient | Zaleplon | true | Inferred relationship | Some | 1 | |
| Zaleplon-containing product | Is a | Gamma-aminobutyric acid A receptor agonist-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zaleplon only product | Is a | True | Zaleplon-containing product | Inferred relationship | Some | |
| Zaleplon 5 mg oral capsule | Is a | False | Zaleplon-containing product | Inferred relationship | Some | |
| Zaleplon 10 mg oral capsule | Is a | False | Zaleplon-containing product | Inferred relationship | Some | |
| Zaleplon-containing product in oral dose form | Is a | True | Zaleplon-containing product | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
FHIR